Purpura Hemorrhagica

Purpura Hemorrhagica ITP: Symptoms, Causes, Types, Diagnosis, and Treatments

Introduction

Purpura Hemorrhagica ITP is a complex bleeding disorder that can cause alarming symptoms and pose significant health challenges if left untreated. While the terms “purpura hemorrhagica” and “ITP” (Idiopathic Thrombocytopenic Purpura) are sometimes used interchangeably, it is important to understand their relationship and distinctions. This article delves deep into the nature of Purpura Hemorrhagica ITP, discussing its symptoms, causes, types, diagnosis, and treatment options.

---

What is Purpura Hemorrhagica ITP?

Purpura hemorrhagica refers to a condition characterized by the spontaneous appearance of purpura—purple-colored spots and patches on the skin caused by bleeding underneath the skin. ITP, or Immune Thrombocytopenic Purpura, is an autoimmune disorder where the body’s immune system mistakenly attacks and destroys platelets, leading to low platelet counts (thrombocytopenia) and causing bleeding manifestations such as purpura.

Purpura Hemorrhagica ITP is essentially ITP presenting with purpura due to severely reduced platelet counts. It is often called immune thrombocytopenic purpura because the immune system plays a key role in platelet destruction.

---

Symptoms of Purpura Hemorrhagica ITP

The hallmark symptoms arise mainly from low platelet levels, which impair blood clotting. Symptoms can range from mild bruising to life-threatening bleeding.

Common Symptoms

• Purpura: Non-blanching purple or red spots on the skin, usually measuring 3 to 10 mm in diameter. These spots do not turn white when pressed.
• Petechiae: Tiny pinpoint red or purple dots caused by minor capillary bleeding.
• Ecchymoses: Larger bruises or patches of bleeding under the skin.
• Mucosal bleeding: Nosebleeds (epistaxis), bleeding gums, and blood in saliva.
• Prolonged bleeding from minor cuts.
• Heavy menstrual bleeding (menorrhagia) in women.
• Fatigue and weakness, which may be due to chronic blood loss.
• Rare severe bleeding such as gastrointestinal bleeding or intracranial hemorrhage, which can be life-threatening.

Symptoms in Severe Cases

• Blood in urine or stools.
• Excessive bleeding after surgery or dental procedures.
• Signs of internal bleeding like abdominal pain, dizziness, or weakness.

---

Causes of Purpura Hemorrhagica ITP

ITP is an autoimmune disorder, meaning the body’s immune system attacks its own platelets. Purpura hemorrhagica is the visible manifestation of this platelet destruction.

Primary (Idiopathic) ITP

• The cause is unknown.
• The immune system produces autoantibodies against platelet surface proteins, leading to platelet destruction mainly in the spleen.

Secondary ITP

Secondary ITP occurs due to an identifiable trigger or underlying disease:

• Infections: Viral infections like HIV, Hepatitis C, Helicobacter pylori, and Epstein-Barr virus can trigger ITP.
• Autoimmune diseases: Systemic lupus erythematosus (SLE), rheumatoid arthritis.
• Medications: Certain drugs can induce immune reactions against platelets (e.g., quinine, sulfonamides).
• Lymphoproliferative disorders: Such as chronic lymphocytic leukemia (CLL).
• Pregnancy: Pregnancy-associated ITP may occur due to immune changes.
• Vaccinations: Rarely, vaccines can trigger ITP.

Pathophysiology

• Autoantibodies bind platelet glycoproteins, mainly GPIIb/IIIa.
• Platelets are opsonized and cleared by macrophages in the spleen.
• Bone marrow attempts to compensate by increasing platelet production but is often insufficient.

---

Types of Purpura Hemorrhagica ITP

ITP is classified based on duration and clinical features:

1. Acute ITP

• Common in children.
• Sudden onset following a viral illness.
• Usually self-limited and resolves within 6 months.
• Symptoms: Purpura, petechiae, bleeding.

2. Chronic ITP

• More common in adults.
• Lasts longer than 6 months.
• May require long-term treatment.
• Symptoms fluctuate with platelet counts.

3. Refractory ITP

• Resistant to conventional treatments.
• Platelet counts remain dangerously low despite therapy.
• Requires advanced or combination therapies.

4. Secondary ITP

• Associated with other diseases or conditions (autoimmune disorders, infections, malignancies).

---

Diagnosis of Purpura Hemorrhagica ITP

Diagnosing Purpura Hemorrhagica ITP involves a thorough clinical assessment and laboratory investigations to exclude other causes of thrombocytopenia and bleeding.

Clinical Evaluation

• Detailed history: Bleeding episodes, recent infections, medications, autoimmune diseases.
• Physical examination: Look for purpura, petechiae, lymphadenopathy, hepatosplenomegaly.

Laboratory Tests

1. Complete Blood Count (CBC)
   • Low platelet count (<100,000/µL, often <30,000 in symptomatic cases).
   • Normal white blood cell and red blood cell counts (rules out bone marrow failure).
2. Peripheral Blood Smear
   • Confirms thrombocytopenia.
   • Checks platelet morphology and excludes platelet clumping.
3. Bone Marrow Examination (if needed)
   • Shows normal or increased megakaryocytes (platelet precursors).
   • Helps rule out leukemia or aplastic anemia.
4. Autoimmune Screening
   • Antinuclear antibodies (ANA), anti-dsDNA if autoimmune disease suspected.
5. Infectious Disease Testing
   • HIV, Hepatitis B and C, Helicobacter pylori.
6. Platelet Antibody Tests
   • Not routinely used due to low sensitivity but can support diagnosis.

Differential Diagnosis

• Other causes of thrombocytopenia: leukemia, aplastic anemia, drug-induced thrombocytopenia, thrombotic thrombocytopenic purpura (TTP), disseminated intravascular coagulation (DIC).
• Vascular disorders causing purpura without thrombocytopenia.
• Coagulation factor deficiencies.

---

Treatment of Purpura Hemorrhagica ITP

Treatment depends on the severity of thrombocytopenia, symptoms, and risk of bleeding.

Goals of Treatment

• Prevent serious bleeding.
• Maintain safe platelet counts (usually >30,000–50,000/µL).
• Improve quality of life.

1. Observation

• For patients with mild thrombocytopenia and no significant bleeding.
• Especially common in children with acute ITP.
• Regular monitoring of platelet counts and symptoms.

2. First-Line Therapies

• Corticosteroids
  • Prednisone or dexamethasone reduces immune destruction of platelets.
  • Given orally or intravenously.
  • Often first-line due to rapid effect.
  • Side effects: weight gain, mood changes, increased infection risk.
• Intravenous Immunoglobulin (IVIG)
  • Used in severe bleeding or to raise platelets rapidly.
  • Blocks Fc receptors on macrophages, reducing platelet destruction.
  • Expensive and short-lived effect.
• Anti-D Immunoglobulin
  • For Rh-positive patients.
  • Less commonly used due to risks of hemolysis.

3. Second-Line Therapies

• For chronic or refractory cases.
• Splenectomy
  • Surgical removal of the spleen.
  • Reduces platelet destruction.
  • Effective in about 60-70% of cases.
  • Risks: infections, thrombosis.
• Thrombopoietin Receptor Agonists (TPO-RAs)
  • Drugs like eltrombopag and romiplostim stimulate platelet production.
  • Used for chronic ITP refractory to other treatments.
• Immunosuppressants
  • Rituximab (anti-CD20 monoclonal antibody).
  • Azathioprine, mycophenolate mofetil, cyclosporine.
  • Used in refractory cases.
• Other Therapies
  • Danazol, dapsone, and other agents have limited use.

4. Supportive Care

• Avoid medications that increase bleeding risk (aspirin, NSAIDs).
• Platelet transfusions reserved for life-threatening bleeding.
• Educate patients about bleeding precautions.
• Manage comorbid conditions.

---

Prognosis

• Children with acute ITP often recover fully without treatment.
• Adults with chronic ITP may have relapses and require long-term management.
• Severe bleeding is uncommon but can be fatal if untreated.
• Early diagnosis and treatment improve outcomes.

---

Living with Purpura Hemorrhagica ITP

• Regular follow-up with a hematologist is important.
• Monitor for symptoms of bleeding.
• Healthy lifestyle and avoidance of injury.
• Psychological support may be necessary due to chronic disease burden.

---

Conclusion

Purpura Hemorrhagica ITP is an autoimmune disorder causing bleeding due to low platelet counts. Recognizing symptoms such as purpura, petechiae, and mucosal bleeding is critical for timely diagnosis. While the exact cause remains unknown in many cases, advances in understanding immune mechanisms have improved diagnosis and treatment options.

Effective management requires a combination of clinical vigilance, laboratory evaluation, and individualized therapy tailored to disease severity. With proper care, most patients lead healthy lives, although chronic cases demand ongoing attention.

Frequently Asked Questions (FAQs) About Purpura Hemorrhagica

For more details keep visiting our Website & Facebook Page.